genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Lentivirus

A Solution to Industry’s Lentiviral Vector Challenge?
Bioprocessing

A Solution to Industry’s Lentiviral Vector Challenge?

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million
Bioprocessing

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service
Bioprocessing

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service

In Vivo Gene Editing Grants Access to Medical Treasures
Genome Editing

In Vivo Gene Editing Grants Access to Medical Treasures

Novel Insights into RNA Modification in HIV-1 Revealed
Infectious Diseases

Novel Insights into RNA Modification in HIV-1 Revealed

Platform Processes May Reduce AAV Gene Therapy Costs
Genome Editing

Platform Processes May Reduce AAV Gene Therapy Costs

Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo
Drug Discovery

Cloaking Device: Liu, Joung Launch $100M Nvelop Therapeutics to Advance Delivery of Genetic Cargo

Vaccines in Development
Infectious Diseases

Vaccines in Development

PROTAC Drug Candidates Could Offer Up Strategy for Eliminating HIV Reservoir
Featured

PROTAC Drug Candidates Could Offer Up Strategy for Eliminating HIV Reservoir

Evotec Expands Anti-HIV Antibody Deal with Advanced BioScience Laboratories
Bioprocessing

Evotec Expands Anti-HIV Antibody Deal with Advanced BioScience Laboratories

123...59Page 1 of 59

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up